Literature DB >> 29789755

Regulatory mechanisms in T cell receptor signalling.

Guillaume Gaud1, Renaud Lesourne2, Paul E Love3.   

Abstract

The remarkable T cell receptor (TCR) performs essential functions in the initiation of intracellular signals required for T cell development, repertoire selection and effector responses to foreign antigens. How TCR signals elicit such diverse cellular responses and outcomes remains a major question for investigation. Recent years have witnessed important advances in our understanding of the regulatory processes that control and modulate the TCR signalling response. Here, we review newly identified mechanisms for the regulation of TCR signalling and then discuss how the TCR signalling response is regulated to control two critical cellular processes - namely, positive selection and T cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29789755     DOI: 10.1038/s41577-018-0020-8

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  128 in total

Review 1.  Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors.

Authors:  Ning Zhu; Shanshan Weng; Juan Wang; Jiaqi Chen; Linzhen Yu; Xuefeng Fang; Ying Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-15       Impact factor: 4.553

2.  Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.

Authors:  Sonoko Kamoshita; Makoto Murata; Daisuke Koyama; Jakrawadee Julamanee; Shingo Okuno; Erina Takagi; Kotaro Miyao; Tatsunori Goto; Yukiyasu Ozawa; Koichi Miyamura; Seitaro Terakura; Tetsuya Nishida; Hitoshi Kiyoi
Journal:  Int J Hematol       Date:  2019-09-26       Impact factor: 2.490

3.  Evaluation of Cytokine Production at the Single Cell Level by Flow Cytometry Upon Polyclonal Stimulation.

Authors:  Jakob Zimmermann
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

5.  T cell receptor and cytokine signal integration in CD8+ T cells is mediated by the protein Themis.

Authors:  Joanna Brzostek; Namrata Gautam; Xiang Zhao; Elijah W Chen; Monika Mehta; Desmond W H Tung; Yen Leong Chua; Jiawei Yap; Su H Cho; Shvetha Sankaran; Vasily Rybakin; Guo Fu; Nicholas R J Gascoigne
Journal:  Nat Immunol       Date:  2020-01-13       Impact factor: 25.606

6.  Relaxation Times of Ligand-Receptor Complex Formation Control T Cell Activation.

Authors:  Hamid Teimouri; Anatoly B Kolomeisky
Journal:  Biophys J       Date:  2020-06-09       Impact factor: 4.033

7.  LRCH1 deficiency enhances LAT signalosome formation and CD8+ T cell responses against tumors and pathogens.

Authors:  Chang Liu; Xiaoyan Xu; Lei Han; Xiaopeng Wan; Lingming Zheng; Chunyang Li; Zhaohui Liao; Jun Xiao; Ruiyue Zhong; Xin Zheng; Qiong Wang; Zonghai Li; Hualan Chen; Bin Wei; Hongyan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-29       Impact factor: 11.205

8.  Modeling and Viewing T Cell Receptors Using TCRmodel and TCR3d.

Authors:  Ragul Gowthaman; Brian G Pierce
Journal:  Methods Mol Biol       Date:  2020

9.  HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane.

Authors:  Wing Fai Li; Manish Aryal; Sherry T Shu; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-03-06       Impact factor: 5.157

10.  Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity.

Authors:  Olli Dufva; Jan Koski; Pilvi Maliniemi; Aleksandr Ianevski; Jay Klievink; Judith Leitner; Petri Pölönen; Helena Hohtari; Khalid Saeed; Tiina Hannunen; Pekka Ellonen; Peter Steinberger; Matti Kankainen; Tero Aittokallio; Mikko A I Keränen; Matti Korhonen; Satu Mustjoki
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.